Patients (pts) with prior CABG have extensive coronary atherosclerosis and are at increased risk for CV events and death. In the ODYSSEY OUTCOMES trial, 18,924 pts with recent ACS and… Click to show full abstract
Patients (pts) with prior CABG have extensive coronary atherosclerosis and are at increased risk for CV events and death. In the ODYSSEY OUTCOMES trial, 18,924 pts with recent ACS and elevated atherogenic lipoprotein levels (e.g., LDL≥70 mg/dL) despite high-intensity statin therapy were
               
Click one of the above tabs to view related content.